Doctor training program aims to boost asthma control
NCT ID NCT05440097
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a program that educates doctors on the latest asthma guidelines can improve how they treat patients. About 1500 people with asthma in China took part. The program included training sessions and reminders to help doctors follow best practices. The main goal was to see if more patients would receive the right kind of inhaler treatment after the program.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Quality improvement program (guideline education and implementation)
What this could lead to
If successful, this program could show that training doctors on asthma guidelines leads to better treatment and control for patients.
What could go wrong
This is a completed study evaluating a program, not testing a new drug. Results may not apply to other countries or healthcare systems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Beijing, 100020, China
-
Research Site
Beijing, 100050, China
-
Research Site
Beijing, 100080, China
-
Research Site
Changchun, 130033, China
-
Research Site
Changsha, 410005, China
-
Research Site
Changzhi, 046000, China
-
Research Site
Chengdu, 610021, China
-
Research Site
Chongqing, 404197, China
-
Research Site
Dalian, 116011, China
-
Research Site
Foshan, 528315, China
-
Research Site
Guangzhou, 510620, China
-
Research Site
Handan, 056000, China
-
Research Site
Harbin, 150001, China
-
Research Site
Hebi, 458000, China
-
Research Site
Hefei, 230011, China
-
Research Site
Huai'an, 223000, China
-
Research Site
Jinan, 250031, China
-
Research Site
Jinhua, 322100, China
-
Research Site
Kunming, 650051, China
-
Research Site
Kunshan, 215316, China
-
Research Site
Nanchang, 331700, China
-
Research Site
Nanning, China
-
Research Site
Ningbo, 315040, China
-
Research Site
Shanghai, 200030, China
-
Research Site
Shanghai, 200080, China
-
Research Site
Shiyan, 442005, China
-
Research Site
Taizhou, 317100, China
-
Research Site
Tianjin, 300450, China
-
Research Site
Wuhu, 241000, China
-
Research Site
Wuyishan, 354300, China
-
Research Site
Xi'an, 710038, China
-
Research Site
Yantai, 265701, China